W Rybka

617 total citations
14 papers, 489 citations indexed

About

W Rybka is a scholar working on Hematology, Oncology and Surgery. According to data from OpenAlex, W Rybka has authored 14 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Oncology and 2 papers in Surgery. Recurrent topics in W Rybka's work include Hematopoietic Stem Cell Transplantation (8 papers), Multiple Myeloma Research and Treatments (3 papers) and Renal Transplantation Outcomes and Treatments (2 papers). W Rybka is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Multiple Myeloma Research and Treatments (3 papers) and Renal Transplantation Outcomes and Treatments (2 papers). W Rybka collaborates with scholars based in United States and Canada. W Rybka's co-authors include C Anasetti, M Banaji, KM Sullivan, Alan Winkelstein, John Lister, SJ Slichter, ED Ball, Peter D’Andrea, M. El-Sawy and Philip E. Pellett and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Stem Cells.

In The Last Decade

W Rybka

13 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W Rybka United States 9 318 158 112 93 53 14 489
Karl G. Blume United States 8 369 1.2× 173 1.1× 99 0.9× 132 1.4× 47 0.9× 9 545
Shulman Hm United States 7 184 0.6× 117 0.7× 85 0.8× 109 1.2× 37 0.7× 7 376
Laurence Clément France 13 167 0.5× 128 0.8× 127 1.1× 120 1.3× 38 0.7× 34 432
R Brown United States 12 371 1.2× 126 0.8× 47 0.4× 159 1.7× 67 1.3× 20 516
Kun Soo Lee South Korea 12 287 0.9× 98 0.6× 71 0.6× 126 1.4× 60 1.1× 43 449
K. W. Chan United States 10 262 0.8× 106 0.7× 35 0.3× 66 0.7× 82 1.5× 15 386
LA Baxter-Lowe United States 10 368 1.2× 98 0.6× 98 0.9× 178 1.9× 59 1.1× 17 505
Hakan Koç Türkiye 10 216 0.7× 96 0.6× 75 0.7× 66 0.7× 47 0.9× 38 369
Ozay Halil United Kingdom 9 162 0.5× 60 0.4× 79 0.7× 38 0.4× 59 1.1× 14 368
Cristina Skert Italy 14 392 1.2× 118 0.7× 52 0.5× 188 2.0× 44 0.8× 21 559

Countries citing papers authored by W Rybka

Since Specialization
Citations

This map shows the geographic impact of W Rybka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Rybka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Rybka more than expected).

Fields of papers citing papers by W Rybka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Rybka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Rybka. The network helps show where W Rybka may publish in the future.

Co-authorship network of co-authors of W Rybka

This figure shows the co-authorship network connecting the top 25 collaborators of W Rybka. A scholar is included among the top collaborators of W Rybka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Rybka. W Rybka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Rakszawski, Kevin, Nathan G. Dolloff, Jeffrey Sivik, et al.. (2011). High-dose melphalan on day 2 versus 1 before autologous stem cell transplantation for multiple myeloma.. Journal of Clinical Oncology. 29(15_suppl). 6545–6545. 1 indexed citations
2.
Schwartz, Jennifer E., et al.. (2003). 109Single-agent tacrolimus for prophylaxis of acute graft-versus-host disease after related allogeneic peripheral blood stem cell transplantation: A phase II study. Biology of Blood and Marrow Transplantation. 9(2). 97–98. 2 indexed citations
3.
4.
5.
Rybka, W, et al.. (1997). Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation. 19(4). 303–310. 103 indexed citations
6.
Magalhaes‐Silverman, Margarida, Albert D. Donnenberg, Elisabeth Elder, et al.. (1996). POST TRANSPLANT IMMUNOTHERAPY IN METASTATIC BREAST CANCER (MBC). Journal of Immunotherapy. 19(6). 461–461. 5 indexed citations
7.
Rybka, W, et al.. (1996). Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation. Blood. 87(12). 5341–5354. 104 indexed citations
8.
Fontes, P., AJ Demetris, A. Zeevi, et al.. (1994). Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart, and pancreas islet transplantation. D-Scholarship@Pitt (University of Pittsburgh). 42 indexed citations
9.
Rybka, W, et al.. (1994). Enumeration of CD34+ hematopoietic stem cells for reconstitution following myeloablative therapy. Cytometry. 16(1). 74–79. 25 indexed citations
10.
Fontes, Paulo, A S Rao, Camillo Ricordi, et al.. (1994). Human bone marrow obtained from vertebral bodies: cell isolation, phenotyping, progenitor assay, and transplantation.. PubMed. 26(6). 3406–7. 3 indexed citations
11.
Paltiel, Ora, Denis Cournoyer, & W Rybka. (1993). Pure red cell aplasia following ABO‐incompatible bone marrow transplantation: response to erythropoietin. Transfusion. 33(5). 418–421. 26 indexed citations
12.
Anasetti, C, W Rybka, KM Sullivan, M Banaji, & SJ Slichter. (1989). Graft-v-host disease is associated with autoimmune-like thrombocytopenia [see comments]. Blood. 73(4). 1054–1058. 82 indexed citations
13.
Anasetti, C, et al.. (1989). Graft-v-host disease is associated with autoimmune-like thrombocytopenia [see comments]. Blood. 73(4). 1054–1058. 79 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karl G. Blume Breakdown of academic impact, for papers by Shulman Hm Breakdown of academic impact, for papers by Laurence Clément Breakdown of academic impact, for papers by R Brown Breakdown of academic impact, for papers by Kun Soo Lee Breakdown of academic impact, for papers by K. W. Chan Breakdown of academic impact, for papers by LA Baxter-Lowe Breakdown of academic impact, for papers by Hakan Koç Breakdown of academic impact, for papers by Ozay Halil Breakdown of academic impact, for papers by Cristina Skert
Rankless by CCL
2026